The Leslie Dan Faculty of Pharmacy at the University of Toronto is a dynamic faculty made up of pharmacy leaders and researchers in the heart of Canada’s thriving healthcare and research ecosystem. From drug discovery to deprescribing, we are exploring and pushing the limits of the profession and the science resulting in better medications, a better health system and better health. Join host Mina Tadrous -- a pharmacist, researcher and Leslie Dan Faculty of Pharmacy Assistant Professor -- from…
Subscribe:.rss.atom.json.md.m3u.pls
Live Last read · last published · next check
Saves to your Listen queue, to pick up on another day or another device.
Misinformation spreads fast—but how do we separate fact from opinion in an increasingly noisy information landscape? In last episode of season five, we dig into misinformation and disinformation in healthcare. We chat with Assistant Professor and Pharmacist Jennifer Lake on the critical difference between misinformation and disinformation and Associate Professor Colin Furness on why expert voices…
Artificial intelligence is transforming healthcare and research—but how much of it is real progress, and how much is hype? In this episode of The I’m Pharmacy Podcast, host Mina Tadrous explores the practical impact of AI across clinical care, population health, and drug discovery. Featuring insights from Dr. Devin Singh (SickKids), Professpr Laura Rosella (University of Toronto), and Assistant…
Pharmacy is changing fast — faster than anyone expected. In this special live episode of I’m Pharmacy, recorded at the Leslie Dan Faculty of Pharmacy, host Mina Tadrous brings together a panel of pharmacists, physicians, learners, and educators to ask a big, urgent question: How do we turn scattered progress in Ontario’s healthcare system into coordinated, collaborative, patient-centred care?…
A few years ago, a bus full of Americans crossed the border into Canada with Senator Bernie Sanders. They weren't coming for sightseeing. They came to buy insulin. Unlike the bus of patients heading north for insulin, most Americans can't simply cross a border to escape the system. They live with it every day. How the U.S. end up with the most expensive drug pricing in the world? In this episode,…
Trump’s Whitehouse is at war with national funding institutions, pausing hundreds of research projects both nationally and internationally. How are Canadian researchers coping with widespread funding cuts, and who pays the price when science is under attack? Featuring: • Bradly Wouters, executive vice-president science and research, University Health Network • Adam Bjorndahl, associate professor,…
We're baaaaaack! Season Five launches September 17. As a sneak peek of what's to come, we sat down with Dr. Mike Fralick on the Rounds Table to chat about the upcoming season, musings on the future of AI and drug discovery, and whether Mike can hold his own in a 90's-style rap battle. Check out episode one of our new season, launching September 17.
In the final episode of the season, we continue our discussion exploring the often overlooked consequences of innovation. In the last episode, we focused on the outcomes of new innovation on existing healthcare systems, exploring ethical access and economic influence. Today, we discuss who innovation can leave behind, and why it is essential that medical breakthroughs benefit everyone. Featuring:…
Like a train moving at a fast pace, innovation can feel unstoppable. In many ways, the only path is forward. But like all good things, we must take a pause to ensure we aren't blinded with the excitement of potential and hope. To end the season, we wanted to use the next two episodes to do just that—pause and explore what we must and should consider as we create this new future with innovations.…
The internet is full of examples of failed innovations... The Segway, The PalmPilot, MySpace... tech that started revolutions, but failed to scale. This phenomenon is not specific to Silicon Valley. In fact, it is very present in healthcare. On this episode of the I'm Pharmacy Podcast, we chat diffusion and implementation. What can innovators learn from failed innovatrions to better navigate the…
So you have a good idea... no, a great idea. The science is solid. The tech is exciting. People are interested. Your innovation and its success seems certain. And yet, you fail to make the jump from an exciting idea to scaling up and being successful. As we explore the art of prototyping, and early launches, we'll explore how these foundational ideas are assessed for market fit. Join us as we…
